Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Price

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|July 17, 2016
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled CorticosteroidsSteve Turner, Kathryn Richardson, Clare Murray, et al.
Multidisciplinary Respiratory Medicine|November 9, 2016
Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-upDavid B Price, Job F M van Boven, Lisa M Law, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"John W Upham, Chantal Le Lievre, David J Jackson, et al.
Pragmatic and Observational Research|June 3, 2017
Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims databaseDavid B Price, Eran Gefen, Gokul Gopalan, et al.
Plos One|January 25, 2018
Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort studyDavid B Price, Eran Gefen, Gokul Gopalan, et al.
BMJ Open|November 25, 2020
Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional studySinthia Bosnic-Anticevich, Peter Smith, Michael Abramson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi ProcessJohn W Upham, Chantal Le Lievre, David J Jackson, et al.
Current Medical Research and Opinion|September 9, 2009
Predictors of asthma control in everyday clinical practice in SwitzerlandAnne B Taegtmeyer, C Steurer-Stey, David B Price, et al.
BMJ Open|August 16, 2019
Understanding reliever overuse in patients purchasing over-the-counter short-acting beta<sub>2</sub> agonists: an Australian community pharmacy-based surveyElizabeth A Azzi, Vicky Kritikos, Matthew J Peters, et al.
Pragmatic and Observational Research|May 2, 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort studyJaco Voorham, Bernard Vrijens, Job Fm van Boven, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Allergy and Clinical Immunology. in Practice|July 17, 2016
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled CorticosteroidsSteve Turner, Kathryn Richardson, Clare Murray, et al.
Multidisciplinary Respiratory Medicine|November 9, 2016
Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-upDavid B Price, Job F M van Boven, Lisa M Law, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2022
Reply to "'Nothing about us without us' - What matters to patients with severe asthma?"John W Upham, Chantal Le Lievre, David J Jackson, et al.
Pragmatic and Observational Research|June 3, 2017
Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims databaseDavid B Price, Eran Gefen, Gokul Gopalan, et al.
Plos One|January 25, 2018
Real-life effectiveness and safety of salbutamol Steri-Neb™ vs. Ventolin Nebules® for exacerbations in patients with COPD: Historical cohort studyDavid B Price, Eran Gefen, Gokul Gopalan, et al.
BMJ Open|November 25, 2020
Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional studySinthia Bosnic-Anticevich, Peter Smith, Michael Abramson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 16, 2021
Defining a Severe Asthma Super-Responder: Findings from a Delphi ProcessJohn W Upham, Chantal Le Lievre, David J Jackson, et al.
Current Medical Research and Opinion|September 9, 2009
Predictors of asthma control in everyday clinical practice in SwitzerlandAnne B Taegtmeyer, C Steurer-Stey, David B Price, et al.
BMJ Open|August 16, 2019
Understanding reliever overuse in patients purchasing over-the-counter short-acting beta<sub>2</sub> agonists: an Australian community pharmacy-based surveyElizabeth A Azzi, Vicky Kritikos, Matthew J Peters, et al.
Pragmatic and Observational Research|May 2, 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort studyJaco Voorham, Bernard Vrijens, Job Fm van Boven, et al.
Pageof 19